Islam, Jessica Y.Gurbani, ArshyaRamos, SilvinaMorgan, KarenKim, Chan JooRichter, Karin LouiseDe Sanjose, SilviaSmith, Jennifer S.Vielot, Nadja A.2022-11-092022-11-092021-08Islam, J.Y., Gurbani, A., Ramos, S. et al. 2021, 'Health care provider perceptions of facilitators and barriers to human papillomavirus vaccination delivery in five countries', Sexually Transmitted Diseases, vol. 48, no. 8, pp. 557-564, doi : 10.1097/OLQ.0000000000001389.0148-5717 (print)1537-4521 (online)10.1097/OLQ.0000000000001389https://repository.up.ac.za/handle/2263/88212BACKGROUND : National human papillomavirus (HPV) vaccination programs could reduce global cervical cancer morbidity and mortality with support from health care providers. We assessed providers' perceptions of HPV vaccination in 5 countries. METHODS : We identified providers from 5 countries where national HPV vaccination programs were at various stages of implementation: Argentina, Malaysia, South Africa, South Korea, and Spain. Providers authorized to administer adolescent vaccines completed an in-depth survey, reporting perceptions of barriers and facilitators to initiating and completing HPV vaccination, and logistical challenges to HPV vaccination. RESULTS : Among 151 providers, common barriers to HPV vaccination initiation across all countries were parents' lack of awareness (39%), concerns about vaccine safety or efficacy (33%), and cost to patients (30%). Vaccination education campaign (70%) was the most commonly cited facilitator of HPV vaccination initiation. Common barriers to series completion included no reminder system or dosing schedule (37%), loss to follow-up or forgetting appointment (29%), and cost to patients (25%). Cited facilitators to completing the vaccine series were education campaigns (45%), affordable vaccination (32%), and reminder/recall systems (22%). Among all countries, high cost of vaccination was the most common logistical challenge to offering vaccination to adolescents (33%). CONCLUSIONS : Incorporating provider insights into future HPV vaccination programs could accelerate vaccine delivery to increase HPV vaccination rates globally.en© 2021 by the American Sexually Transmitted Diseases Association. This is a non-final version of an article published in final form in Sexually Transmitted Diseases, vol. 48, no. 8, pp. 557-564, 2021, doi : 10.1097/OLQ.0000000000001389.Human papillomavirus (HPV)VaccinationHealthcarePostprint Article